MYC and chronic myelogenous leukemia, BCR-ABL1 positive: These can include deregulated expression by the juxtaposition of promoters or enhancers from other chromosomes such as translocation of c-myc under the enhancer of the IgH locus or fusion of genes on two separate chromosomes such as translocation leading to chronic myeloid leukemia (CML) and B cell acute lymphocytic leukemia (B-ALL).